Belatacept-based immunosuppression: A calcineurin inhibitor-sparing regimen in heart transplant recipients.
Am J Transplant
; 20(2): 553-563, 2020 02.
Article
in En
| MEDLINE
| ID: mdl-31452337
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Heart Transplantation
/
Immunosuppression Therapy
/
Abatacept
/
Graft Rejection
/
Immunosuppressive Agents
Type of study:
Observational_studies
Limits:
Adult
/
Aged
/
Female
/
Humans
/
Male
/
Middle aged
Language:
En
Journal:
Am J Transplant
Journal subject:
TRANSPLANTE
Year:
2020
Document type:
Article
Affiliation country:
France
Country of publication:
United States